(ASB) Associated Banc-Corp - Ratings and Ratios
Loans, Deposits, Cash Management, Investment Services, Trust
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.46% |
| Yield on Cost 5y | 5.90% |
| Yield CAGR 5y | 5.18% |
| Payout Consistency | 89.9% |
| Payout Ratio | 36.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 32.2% |
| Value at Risk 5%th | 45.5% |
| Relative Tail Risk | -13.98% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.50 |
| Alpha | -3.97 |
| CAGR/Max DD | 0.24 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.450 |
| Beta | 1.156 |
| Beta Downside | 1.267 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.58% |
| Mean DD | 13.41% |
| Median DD | 10.16% |
Description: ASB Associated Banc-Corp November 07, 2025
Associated Banc-Corp (NYSE: ASB) is a regional bank holding company headquartered in Green Bay, Wisconsin, that serves individuals and businesses across Wisconsin, Illinois, Missouri and Minnesota. The firm delivers a full spectrum of banking and non-banking products-including commercial and residential loans, asset-based and equipment financing, deposit and cash-management services, fiduciary and trust administration, as well as investment and brokerage solutions-and maintains loan-production offices in Indiana, Kansas, Michigan, New York, Ohio and Texas.
As of the latest quarter (Q3 2024), ASB reported a net interest margin of roughly 3.6%, a loan portfolio that grew about 5% year-over-year to approximately $22 billion, and deposits near $30 billion, reflecting modest but steady balance-sheet expansion. The regional-bank sector remains highly sensitive to Federal Reserve policy and Midwest commercial-real-estate trends; however, ASB’s non-performing loan ratio stays under 0.5%, indicating relatively strong credit quality amid a tightening credit environment.
For a deeper quantitative breakdown of ASB’s valuation drivers, the ValueRay platform offers a granular, data-rich analysis worth exploring.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (176.0m TTM) > 0 and > 6% of Revenue (6% = 128.9m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 0.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1705 % (prev -1349 %; Δ -356.0pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.01 (>3.0%) and CFO 604.7m > Net Income 176.0m (YES >=105%, WARN >=100%) |
| Net Debt (2.92b) to EBITDA (340.8m) ratio: 8.57 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.04 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (166.7m) change vs 12m ago 10.04% (target <= -2.0% for YES) |
| Gross Margin 50.69% (prev 45.93%; Δ 4.76pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 4.96% (prev 5.16%; Δ -0.20pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.24 (EBITDA TTM 340.8m / Interest Expense TTM 995.3m) >= 6 (WARN >= 3) |
Altman Z'' -5.06
| (A) -0.82 = (Total Current Assets 1.46b - Total Current Liabilities 38.09b) / Total Assets 44.46b |
| (B) 0.07 = Retained Earnings (Balance) 3.13b / Total Assets 44.46b |
| (C) 0.01 = EBIT TTM 237.3m / Avg Total Assets 43.33b |
| (D) 0.08 = Book Value of Equity 3.12b / Total Liabilities 39.59b |
| Total Rating: -5.06 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 59.38
| 1. Piotroski 3.0pt |
| 2. FCF Yield 7.94% |
| 3. FCF Margin 26.69% |
| 4. Debt/Equity 0.87 |
| 5. Debt/Ebitda 8.57 |
| 6. ROIC - WACC (= -5.16)% |
| 7. RoE 3.72% |
| 8. Rev. Trend 70.43% |
| 9. EPS Trend 39.11% |
What is the price of ASB shares?
Over the past week, the price has changed by +3.63%, over one month by +2.87%, over three months by +1.95% and over the past year by +15.53%.
Is ASB a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 8
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ASB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29.4 | 9.4% |
| Analysts Target Price | 29.4 | 9.4% |
| ValueRay Target Price | 29.8 | 10.8% |
ASB Fundamental Data Overview January 01, 2026
P/E Trailing = 30.1512
P/E Forward = 9.1324
P/S = 3.9195
P/B = 0.9205
P/EG = 2.27
Beta = 0.812
Revenue TTM = 2.15b USD
EBIT TTM = 237.3m USD
EBITDA TTM = 340.8m USD
Long Term Debt = 1.00b USD (from longTermDebt, last quarter)
Short Term Debt = 3.21b USD (from shortTermDebt, last quarter)
Debt = 4.21b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.92b USD (from netDebt column, last quarter)
Enterprise Value = 7.22b USD (4.30b + Debt 4.21b - CCE 1.29b)
Interest Coverage Ratio = 0.24 (Ebit TTM 237.3m / Interest Expense TTM 995.3m)
FCF Yield = 7.94% (FCF TTM 573.4m / Enterprise Value 7.22b)
FCF Margin = 26.69% (FCF TTM 573.4m / Revenue TTM 2.15b)
Net Margin = 8.19% (Net Income TTM 176.0m / Revenue TTM 2.15b)
Gross Margin = 50.69% ((Revenue TTM 2.15b - Cost of Revenue TTM 1.06b) / Revenue TTM)
Gross Margin QoQ = 57.98% (prev 56.78%)
Tobins Q-Ratio = 0.16 (Enterprise Value 7.22b / Total Assets 44.46b)
Interest Expense / Debt = 5.96% (Interest Expense 251.4m / Debt 4.21b)
Taxrate = 19.16% (29.6m / 154.3m)
NOPAT = 191.8m (EBIT 237.3m * (1 - 19.16%))
Current Ratio = 0.04 (Total Current Assets 1.46b / Total Current Liabilities 38.09b)
Debt / Equity = 0.87 (Debt 4.21b / totalStockholderEquity, last quarter 4.87b)
Debt / EBITDA = 8.57 (Net Debt 2.92b / EBITDA 340.8m)
Debt / FCF = 5.10 (Net Debt 2.92b / FCF TTM 573.4m)
Total Stockholder Equity = 4.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.40% (Net Income 176.0m / Total Assets 44.46b)
RoE = 3.72% (Net Income TTM 176.0m / Total Stockholder Equity 4.74b)
RoCE = 4.13% (EBIT 237.3m / Capital Employed (Equity 4.74b + L.T.Debt 1.00b))
RoIC = 2.42% (NOPAT 191.8m / Invested Capital 7.94b)
WACC = 7.57% (E(4.30b)/V(8.52b) * Re(10.27%) + D(4.21b)/V(8.52b) * Rd(5.96%) * (1-Tc(0.19)))
Discount Rate = 10.27% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.39%
[DCF Debug] Terminal Value 70.49% ; FCFE base≈499.2m ; Y1≈497.0m ; Y5≈522.8m
Fair Price DCF = 38.84 (DCF Value 6.45b / Shares Outstanding 165.9m; 5y FCF grow -1.10% → 3.0% )
EPS Correlation: 39.11 | EPS CAGR: 11.22% | SUE: 2.96 | # QB: 5
Revenue Correlation: 70.43 | Revenue CAGR: 24.28% | SUE: 1.14 | # QB: 13
EPS next Quarter (2026-03-31): EPS=0.67 | Chg30d=+0.003 | Revisions Net=+2 | Analysts=8
EPS next Year (2026-12-31): EPS=2.83 | Chg30d=+0.029 | Revisions Net=+4 | Growth EPS=+4.8% | Growth Revenue=+10.3%
Additional Sources for ASB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle